Pluristem Therapeutics Inc. announced the appointment of Ms. Maital Shemesh-Rasmussen and Mr. Rami Levi to its Board of Directors. Ms. Maital Shemesh-Rasmussen brings over 20 years of diverse commercialization experience across various industries. From 2018 to 2020, she served as Global Head of Solution Marketing at Roche Diagnostics Information Solutions, where she defined Roche's new health-tech strategy, bringing to market advanced digital solutions and commercial models that positioned Roche as a world leader in health technology. Mr. Rami Levi, Founder and President of Catalyst Group International, brings over 30 years of experience in managing successful international projects on five continents, partnering with world leaders, and connecting nations and industry on a global scale.